Treatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSaglik Bilimleri Universitesi

About this trial

The use of injectable platelet-rich fibrin (i-PRF) in both surgical and non-surgical dental treatments has become increasingly widespread. Hard tissue grafts can produce "sticky bone," and bone gain can have a positive effect on intrabony defects frequently seen in periodontal disease, compared to grafts alone. This study aims to clinically and radiographically evaluate the effectiveness of using bovine-derived xenogenic bone grafts in combination with i-PRF and bovine-derived xenogeneic bone grafts alone in patients with intrabony defects and stage III periodontitis.

Eligibility criteria

Qualifiers

Male and female patients aged 18-65 years

Patients with Stage III Periodontitis according to the AAP-EFP 2017 Periodontal Disease Classification

PPD≥5 mm (if persistent 6 weeks after initial periodontal treatment)

Intrabony defects in the interproximal region with 2 or 3 walls and a depth of at least ≥3 mm

Disqualifiers

Patients under 18 years of age or older than 65 years of age

Patients unable to consent

Systemic diseases that could affect the success of surgery, such as uncontrolled diabetes

Single-walled intrabony defects

Trial design

Treatments tested in this trial

  • open flap debridement with I-prf and xenogeneic graft
  • open flap debridement with saline and xenogenic graft

Treatment groups

16 Participants
are divided into 2 treatment groups

Sponsors and collaborators